ARYx Therapeutics Inc (ARYX)
US Market

ARYx Therapeutics Financial Statements


ARYx Therapeutics Financial Overview

ARYx Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; ARYx Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 10Jun 10Mar 10Dec 09Sep 09
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBIT$ -2.15M$ -3.24M$ -6.02M$ -5.32M$ -7.63M
EBITDA$ -1.94M$ -3.01M$ -5.77M$ -5.06M$ -7.45M
Net Income Common Stockholders$ -2.51M$ -3.64M$ -6.39M$ -5.79M$ -8.15M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 1.40M$ 2.95M$ 6.30M$ 7.76M$ 14.19M
Total Assets$ 5.97M$ 5.02M$ 10.57M$ 12.41M$ 19.29M
Total Debt$ 7.75M$ 9.49M$ 10.68M$ 13.43M$ 14.34M
Net Debt$ 6.35M$ 6.54M$ 4.38M$ 5.67M$ 157.00K
Total Liabilities$ 13.71M$ 10.95M$ 12.98M$ 15.32M$ 17.47M
Stockholders Equity$ 1.82M$ -7.74M$ -5.93M$ -2.40M$ -2.92M
Cash Flow
Free Cash Flow$ -4.05M$ -3.52M$ -6.42M$ -6.13M$ -6.80M
Operating Cash Flow$ -4.05M$ -3.52M$ -6.42M$ -6.08M$ -6.79M
Investing Cash Flow$ 273.00K$ 204.00K$ 370.00K$ 7.26M$ 3.08M
Financing Cash Flow$ 5.32M$ -1.58M$ 4.94M$ -616.00K$ -1.38M
Currency in USD

ARYx Therapeutics Earnings and Revenue History

ARYx Therapeutics Debt to Assets

ARYx Therapeutics Cash Flow

ARYx Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis